サマリー

画像診断サービス市場は、2022年の5,490億米ドルから2027年には7,026億米ドルに達すると予測され、予測期間中のCAGRは5.1%となります。市場成長の主な要因は、世界的な各種慢性疾患の発生率の上昇、さまざまな画像診断法に関する認知度の向上、外来画像診断センターの拡大などです。

しかし、画像診断機器にかかるコストの高さ、低経済国での新しい画像技術の採用の減少、熟練労働者の不足などが市場の成長を抑制すると予想されます。

"2021年の世界の画像診断サービス市場では、X線が最大のシェアを占めた"。
モダリティに基づき、市場はX線 、コンピュータ断層撮影、超音波、MRI、核画像、マンモグラフィーに区分される。2021年の画像診断サービス市場では、X線分野が最大のシェアを占めています。これは、世界中の病院や診断センターでデジタルX線画像診断モダリティの利用が増加していることに起因しています。また、CTスキャナーの10倍の解像度で全身の3D画像を提供するHiP-CT（Hierarchical Phase-Contrast Tomography）など、X線スキャンの技術的なアップグレードが進んでおり、近い将来、このセグメントの成長をサポートすると予想されます。

"2021年のMRI画像サービス市場では、神経分野が最大のシェアを占めている"。
アプリケーションに基づいて、MRIサービス市場は、神経学、整形外科、心血管、骨盤＆腹部、腫瘍学に区分されます。2021年のMRIサービス市場では、神経学分野が最大のシェアを占めています。これは、高齢者人口の増加や神経変性疾患、外傷性脳損傷の発生率の増加、MRIイメージング技術の進歩、さまざまな神経疾患の予測のために新しいMRI技術を導入するプレイヤーの増加などに起因しています。

アジア太平洋地域は、予測期間中に最も高いCAGRで成長すると推定されます。
画像診断サービス市場は、北米、欧州、アジア太平洋地域、中南米、中東・アフリカの4つの主要地域に区分されます。2021年、北米は世界の画像診断サービス市場で最大のシェアを占めました。しかし、アジア太平洋地域は、医療インフラの改善、画像診断への投資の増加、償還シナリオの改善、医療観光の増加、APAC諸国における保険適用の拡大などを主な理由として、予測期間中に最高のCAGR 6.1%d で成長すると推測されます。さらに、アジア諸国における新たな診断センターや病院の設立が、予測期間中のアジア太平洋地域の市場成長を促進するものと期待されています。

供給側の一次インタビュー内訳
- 企業タイプ別ティア1：48%、ティア2：36%、ティア3：16
- 役職別Cレベル：10％、ディレクターレベル：14％、その他：76
- 地域別地域別：北米40％、欧州32％、APAC20％、RoW8％。

市場の主要プレイヤーは、RadNet, Inc.（米国）、Sonic Healthcare（オーストラリア）、Akumin Inc.(米国）、Healius Limited（オーストラリア）、RAYUS Radiology（米国）、Dignity Health（米国）、Novant Health（米国）、Alliance Medical（英国）、InHealth Group（英国）、Apex Radiology（オーストラリア）、Concord Medical Services Holdings Limited（中国）、Unilabs（スイス）、Affidea（オランダ）、I-MED Radiology Network（オーストラリア）、Capitol Imaging Services（米国）、SimonMed（米国）などとなっています。

調査対象範囲
この調査レポートは、画像診断サービス市場をモダリティ、アプリケーション、技術、エンドユーザー、地域別に分類しています。また、市場成長に影響を与える要因（促進要因、阻害要因、機会、課題など）を調査し、市場リーダー向けの競争環境の詳細も記載しています。さらに、個々の成長傾向に関してミクロ市場を分析し、主要5地域（およびこれらの地域のそれぞれの国）に関して市場セグメントの収益を予測しています。


レポート購入の主なメリット
本レポートでは、様々なレベルの分析-産業動向、トップ企業の市場シェア、企業プロファイル-に焦点を当て、これらを合わせて基本的な見解を形成し、競争環境、世界の画像診断サービス市場の新興セグメント、高成長地域とその推進要因、阻害要因、機会、課題などを分析します。本レポートは、既存企業だけでなく、新規参入企業/中小企業にとっても、市場の動向を把握し、より大きな市場シェアを獲得するための一助となることでしょう。

ページTOPに戻る

目次

1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 29
1.3 MARKET SCOPE 30
1.3.1 MARKETS COVERED 30
1.3.2 GEOGRAPHIC SCOPE 31
1.3.3 INCLUSIONS & EXCLUSIONS 31
1.3.4 YEARS CONSIDERED 31
1.4 CURRENCY CONSIDERED 32
1.5 LIMITATIONS 32
1.6 MARKET STAKEHOLDERS 32
1.7 SUMMARY OF CHANGES 32
2 RESEARCH METHODOLOGY 34
2.1 RESEARCH METHODOLOGY 34
FIGURE 1 RESEARCH DESIGN 34
2.1.1 SECONDARY RESEARCH 35
2.1.2 PRIMARY RESEARCH 36
2.1.2.1 Key data from primary sources 36
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 37
FIGURE 3 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 37
2.2 MARKET SIZE ESTIMATION 38
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 38
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 39
2.2.2 DIAGNOSTIC IMAGING SERVICES CONSUMPTION-BASED MARKET ESTIMATION 39
FIGURE 5 MARKET SIZE ESTIMATION: OVERALL DIAGNOSTIC IMAGING SERVICES MARKET 40
2.2.3 PRIMARY RESEARCH VALIDATION 40
2.3 DATA TRIANGULATION 41
FIGURE 6 DIAGNOSTIC IMAGING SERVICES MARKET: DATA TRIANGULATION METHODOLOGY 41
2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS 42
2.4.1 RESEARCH ASSUMPTIONS 42
2.4.2 RESEARCH LIMITATIONS 42
 
3 EXECUTIVE SUMMARY 43
FIGURE 7 DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2022 VS. 2027 (USD BILLION) 43
FIGURE 8 X-RAY IMAGING MARKET, BY APPLICATION, 2022 VS. 2027 (USD BILLION) 44
FIGURE 9 DIAGNOSTIC IMAGING SERVICES MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD BILLION) 44
FIGURE 10 DIAGNOSTIC IMAGING SERVICES MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 45
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF DIAGNOSTIC IMAGING SERVICES MARKET 46
4 PREMIUM INSIGHTS 47
4.1 DIAGNOSTIC IMAGING SERVICES MARKET OVERVIEW 47
FIGURE 12 EARLY DISEASE DETECTION AND RISING INCIDENCE OF AGE-ASSOCIATED DISEASES TO DRIVE MARKET 47
4.2 DIAGNOSTIC IMAGING SERVICES MARKET FOR COMPUTED TOMOGRAPHY (CT) APPLICATION, 2022 VS. 2027 (USD BILLION) 48
FIGURE 13 CARDIOVASCULAR SEGMENT TO DOMINATE CT MARKET IN 2022 48
4.3 EUROPE: DIAGNOSTIC IMAGING SERVICES MARKET, BY END USER AND COUNTRY 48
FIGURE 14 HOSPITALS SEGMENT IN EUROPE ACCOUNTED FOR LARGEST SHARE IN 2021 48
4.4 GEOGRAPHIC SNAPSHOT OF DIAGNOSTIC IMAGING SERVICES MARKET 49
FIGURE 15 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 49
5 MARKET OVERVIEW 50
5.1 INTRODUCTION 50
5.2 MARKET DYNAMICS 50
FIGURE 16 DIAGNOSTIC IMAGING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 50
5.2.1 DRIVERS 51
5.2.1.1 Rising geriatric population and subsequent increase in age-related diseases 51
TABLE 1 AGE-RELATED DISEASES AND OTHER ASSOCIATED DIAGNOSTIC MODALITIES 51
5.2.1.2 Growing awareness of early disease detection and broad scope of clinical applications 52
TABLE 2 EMERGING APPLICATIONS OF DIAGNOSTIC IMAGING 52
5.2.1.3 Technological advancements in diagnostic imaging 52
5.2.1.4 Growing preference for outpatient imaging centers 53
TABLE 3 HOSPITAL PRICES AS A PERCENTAGE OF OUTPATIENT IMAGING PRICES 53
5.2.2 RESTRAINTS 54
5.2.2.1 High cost of diagnostic imaging systems 54
5.2.2.2 Low reimbursement for outpatient imaging facilities 54
TABLE 4 MEDICARE REIMBURSEMENT TRENDS BY IMAGING MODALITY (2007−2019) 55
5.2.3 OPPORTUNITIES 55
5.2.3.1 Adoption of AI and blockchain 55
5.2.3.2 High growth opportunities in emerging countries 55
5.2.4 CHALLENGES 56
5.2.4.1 Shortage of skilled radiologists 56
5.2.4.2 Hospital budget cuts 56
5.3 PRICING ANALYSIS 56
5.3.1 AVERAGE SELLING PRICE OF DIAGNOSTIC IMAGING SERVICES BY KEY PLAYERS 56
TABLE 5 MODALITY - MRI SCAN 56
TABLE 6 MODALITY – CT SAN 57
TABLE 7 MODALITY – X-RAY 57
TABLE 8 MODALITY – PET SCAN 57
TABLE 9 AVERAGE SELLING PRICE OF DIAGNOSTIC IMAGING MODALITY TREND (USD) 57
5.4 ECOSYSTEM ANALYSIS: DIAGNOSTIC IMAGING SERVICES MARKET 58
5.5 REGULATORY ANALYSIS 58
TABLE 10 KEY REGULATORY BODIES & GOVERNMENT AGENCIES 58
5.5.1 KEY REGULATORY GUIDELINES 58
5.5.1.1 US 58
TABLE 11 US FDA: MEDICAL DEVICE CLASSIFICATION 59
TABLE 12 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 59
5.5.1.2 Canada 60
TABLE 13 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 60
5.5.1.3 Europe 60
5.5.1.4 Japan 61
TABLE 14 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 61
5.5.1.5 China 62
TABLE 15 CHINA: CLASSIFICATION OF MEDICAL DEVICES 62
5.5.1.6 India 63
5.6 REIMBURSEMENT SCENARIO 64
TABLE 16 MEDICAL REIMBURSEMENT CPT CODES FOR MRI PROCEDURES (AS OF 2022) (US) 64
TABLE 17 MEDICAL REIMBURSEMENT CPT CODES FOR CT IMAGING PROCEDURES (AS OF 2022) (US) 65
TABLE 18 MEDICAL REIMBURSEMENT CODES FOR PET/CT IMAGING PROCEDURES (AS OF 2022) (US) 67
TABLE 19 MEDICAL REIMBURSEMENT CODES FOR ULTRASOUND IMAGING PROCEDURES (AS OF 2021) (US) 67
TABLE 20 MEDICAL REIMBURSEMENT CODES FOR MAMMOGRAPHY IMAGING PROCEDURES (AS OF 2021) (US) 67
TABLE 21 MEDICAL REIMBURSEMENT CODES FOR X-RAY IMAGING PROCEDURES (AS OF 2021) (US) 68
5.6.1 COMMERCIAL REIMBURSEMENT: DIAGNOSTIC IMAGING SERVICES 68
5.7 VALUE CHAIN ANALYSIS 68
5.7.1 RESEARCH & DEVELOPMENT 68
5.7.2 MANUFACTURING & ASSEMBLY 68
5.7.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES 68
FIGURE 17 VALUE CHAIN ANALYSIS 69
5.8 PORTER'S FIVE FORCES ANALYSIS 69
5.8.1 OVERVIEW 69
TABLE 22 DIAGNOSTIC IMAGING SERVICE MARKET: PORTER'S FIVE FORCES ANALYSIS 69
5.8.2 BARGAINING POWER OF BUYERS 69
5.8.3 BARGAINING POWER OF SUPPLIERS 70
5.8.4 THREAT OF NEW ENTRANTS 71
5.8.5 THREAT OF SUBSTITUTES 71
5.8.6 INTENSITY OF COMPETITIVE RIVALRY 72
5.9 PATENT ANALYSIS 73
FIGURE 18 MAJOR PATENT HOLDERS FOR ULTRASOUND IMAGING SYSTEMS (JANUARY 2011 TO AUGUST 2022) 73
FIGURE 19 MAJOR PATENT HOLDERS FOR MAGNETIC RESONANCE IMAGING SYSTEMS (JANUARY 2011 TO AUGUST 2022) 73
FIGURE 20 MAJOR PATENT HOLDERS FOR CT IMAGING SYSTEMS (JANUARY 2011 TO AUGUST 2022) 74
FIGURE 21 MAJOR PATENT HOLDERS FOR MAMMOGRAPHY SYSTEMS (JANUARY 2011 TO AUGUST 2022) 74
FIGURE 22 MAJOR PATENT HOLDERS FOR NUCLEAR IMAGING SYSTEMS (JANUARY 2011 TO AUGUST 2022) 75
FIGURE 23 MAJOR PATENT HOLDERS FOR X-RAY SYSTEMS (JANUARY 2011 TO AUGUST 2022) 75
FIGURE 24 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR DIAGNOSTIC IMAGING PATENTS, 2011–2022 76
5.10 KEY CONFERENCES & EVENTS (2022–2023) 76
TABLE 23 DIAGNOSTIC IMAGING SERVICES MARKET: DETAILED LIST OF MAJOR CONFERENCES & EVENTS 76
5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 77
FIGURE 25 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX 77
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 78
5.12.1 KEY STAKEHOLDERS 78
FIGURE 26 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESSES FOR DIFFERENT IMAGING MODALITIES/PROCEDURES 78
TABLE 24 INFLUENCE OF STAKEHOLDERS PURCHASING SERVICES FOR TOP 3 IMAGING MODALITIES/PROCEDURES (%) 78
5.13 KEY BUYING CRITERIA, BY END USER 79
TABLE 25 KEY BUYING CRITERIA FOR BUYING MODALITY SEGMENTS 79
6 DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY 80
6.1 INTRODUCTION 81
TABLE 26 DIAGNOSTIC IMAGING SERVICES MARKET, BY REGION, 2020–2027 (USD BILLION) 81
TABLE 27 DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION) 81
 
6.2 MAGNETIC RESONANCE IMAGING (MRI) 82
6.2.1 ACCURATE DISEASE STAGING AND EFFECTIVE RESPONSE IN TREATMENT OF CHRONIC CONDITIONS TO DRIVE MARKET 82
TABLE 28 MAGNETIC RESONANCE IMAGING SERVICES MARKET, BY REGION, 2020–2027 (USD BILLION) 82
TABLE 29 MAGNETIC RESONANCE IMAGING SERVICES MARKET, BY END USER, 2020–2027 (USD BILLION) 83
6.3 ULTRASOUND 83
6.3.1 RISING DEVELOPMENT OF POC ULTRASOUND SYSTEMS TO SUPPORT MARKET GROWTH 83
TABLE 30 ULTRASOUND SERVICES MARKET, BY REGION, 2020–2027 (USD BILLION) 84
TABLE 31 ULTRASOUND SERVICES MARKET, BY END USER, 2020–2027 (USD BILLION) 84
6.4 COMPUTED TOMOGRAPHY (CT) 84
6.4.1 RISING ADOPTION OF CT SCANNERS FOR DETECTION OF TUMORS TO SUPPORT MARKET GROWTH 84
TABLE 32 COMPUTED TOMOGRAPHY SERVICES MARKET, BY REGION, 2020–2027 (USD BILLION) 85
TABLE 33 COMPUTED TOMOGRAPHY SERVICES MARKET, BY END USER, 2020–2027 (USD BILLION) 85
6.5 X-RAY 86
6.5.1 LOWER COST OF X-RAY IMAGING COMPARED TO OTHER MODALITIES TO DRIVE MARKET 86
TABLE 34 X-RAY SERVICES MARKET, BY REGION, 2020–2027 (USD BILLION) 86
TABLE 35 X-RAY SERVICES MARKET, BY END USER, 2020–2027 (USD BILLION) 87
6.6 NUCLEAR IMAGING (SPECT/PET) 87
6.6.1 STRINGENT REGULATIONS AND UNCERTAIN REIMBURSEMENT SCENARIOS TO RESTRAIN MARKET 87
TABLE 36 NUCLEAR IMAGING SERVICES MARKET, BY REGION, 2020–2027 (USD BILLION) 88
TABLE 37 NUCLEAR IMAGING SERVICES MARKET, BY END USER, 2020–2027 (USD BILLION) 88
6.7 MAMMOGRAPHY 88
6.7.1 RISING BREAST CANCER CASES TO DRIVE DEMAND FOR 3D MAMMOGRAMS 88
TABLE 38 MAMMOGRAPHY SERVICES MARKET, BY REGION, 2020–2027 (USD BILLION) 89
TABLE 39 MAMMOGRAPHY SERVICES MARKET, BY END USER, 2020–2027 (USD BILLION) 90
7 DIAGNOSTIC IMAGING SERVICES MARKET, BY APPLICATION 91
7.1 INTRODUCTION 92
TABLE 40 DIAGNOSTIC IMAGING SERVICES MARKET, BY APPLICATION, 2020–2027 (USD BILLION) 92
7.2 MAGNETIC RESONANCE IMAGING (MRI) 92
TABLE 41 DIAGNOSTIC IMAGING SERVICES MARKET FOR MAGNETIC RESONANCE IMAGING, BY APPLICATION, 2020–2027 (USD BILLION) 93
 
7.2.1 NEUROLOGY 93
7.2.1.1 Innovations in 3D MRI technology to have wide applications in neurology 93
7.2.2 ORTHOPEDICS 94
7.2.2.1 MRI procedures to be effective in diagnosis & prognosis of musculoskeletal disorders 94
TABLE 42 MAGNETIC RESONANCE IMAGING SERVICES MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2020–2027 (USD BILLION) 94
7.2.3 CARDIOVASCULAR 94
7.2.3.1 MRI helps obtain high-resolution images of vascular systems 94
TABLE 43 MAGNETIC RESONANCE IMAGING SERVICES MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2020–2027 (USD BILLION) 95
7.2.4 PELVIC & ABDOMEN 95
7.2.4.1 Rising cases of kidney stones among individuals to support market growth 95
TABLE 44 MAGNETIC RESONANCE IMAGING SERVICES MARKET FOR PELVIC & ABDOMEN APPLICATIONS, BY REGION, 2020–2027 (USD BILLION) 96
7.2.5 ONCOLOGY 96
7.2.5.1 Rising prevalence of cancer and increasing awareness of early cancer screening to drive market 96
7.2.6 OTHER MRI APPLICATIONS 96
7.3 ULTRASOUND 97
TABLE 45 DIAGNOSTIC IMAGING SERVICES MARKET FOR ULTRASOUND, BY APPLICATION, 2020–2027 (USD BILLION) 97
7.3.1 OBSTETRICS & GYNECOLOGY 97
7.3.1.1 Rising number of maternity centers and diagnostic clinics to support market 97
TABLE 46 ULTRASOUND IMAGING SERVICES MARKET FOR OBSTETRICS & GYNECOLOGY APPLICATIONS, BY REGION, 2020–2027 (USD BILLION) 98
7.3.2 CARDIOVASCULAR 98
7.3.2.1 Increasing lifestyle changes and age-related disorders to drive market 98
TABLE 47 ULTRASOUND IMAGING SERVICES MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2020–2027 (USD BILLION) 99
7.3.3 UROLOGY 99
7.3.3.1 Growing incidence of urological disorders to support market growth 99
TABLE 48 ULTRASOUND IMAGING SERVICES MARKET FOR UROLOGY APPLICATIONS, BY REGION, 2020–2027 (USD BILLION) 100
7.3.4 NEUROLOGY 100
7.3.4.1 Increasing incidence of neuromuscular disorders to drive market 100
TABLE 49 ULTRASOUND IMAGING SERVICES MARKET FOR NEUROLOGY APPLICATIONS, BY REGION, 2020–2027 (USD BILLION) 101
7.3.5 ORTHOPEDICS 101
7.3.5.1 Increasing use of ultrasound in orthopedics due to absence of harmful ionization radiation 101
TABLE 50 ULTRASOUND IMAGING SERVICES MARKET FOR ORTHOPEDICS APPLICATIONS, BY REGION, 2020–2027 (USD BILLION) 102
7.3.6 OTHER ULTRASOUND APPLICATIONS 102
TABLE 51 ULTRASOUND IMAGING SERVICES MARKET FOR OTHER ULTRASOUND APPLICATIONS, BY REGION, 2020–2027 (USD BILLION) 102
7.4 COMPUTED TOMOGRAPHY (CT) 103
TABLE 52 DIAGNOSTIC IMAGING SERVICES MARKET FOR COMPUTED TOMOGRAPHY (CT), BY APPLICATIONS, 2020–2027 (USD BILLION) 103
7.4.1 CARDIOVASCULAR 103
7.4.1.1 Growing availability of cardiac CT devices in imaging to propel market 103
TABLE 53 COMPUTED TOMOGRAPHY MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2020–2027 (USD BILLION) 104
7.4.2 ONCOLOGY 104
7.4.2.1 Increasing incidence of cancer to drive market 104
TABLE 54 COMPUTED TOMOGRAPHY (CT) IMAGING SERVICES MARKET FOR ONCOLOGY APPLICATIONS, BY REGION 2020–2027 (USD BILLION) 105
7.4.3 NEUROLOGY 105
7.4.3.1 High prevalence of target diseases to support market growth 105
TABLE 55 COMPUTED TOMOGRAPHY (CT) IMAGING SERVICES MARKET FOR NEUROLOGY APPLICATIONS, BY REGION 2020–2027 (USD BILLION) 105
7.4.4 OTHER COMPUTED TOMOGRAPHY (CT) APPLICATIONS 106
TABLE 56 COMPUTED TOMOGRAPHY (CT) IMAGING SERVICES MARKET FOR OTHER CT APPLICATIONS, BY REGION 2020–2027 (USD BILLION) 106
7.5 X-RAY 107
TABLE 57 DIAGNOSTIC IMAGING SERVICES MARKET FOR X-RAY APPLICATIONS, 2020–2027 (USD BILLION) 107
7.5.1 GENERAL RADIOGRAPHY 107
7.5.1.1 Rising prevalence of lung diseases to drive market 107
TABLE 58 X-RAY IMAGING SERVICES MARKET FOR GENERAL RADIOLOGY APPLICATIONS, BY REGION, 2020–2027 (USD BILLION) 108
7.5.2 DENTISTRY 108
7.5.2.1 High prevalence of dental disorders to support dental screening 108
TABLE 59 X-RAY IMAGING SERVICES MARKET FOR DENTISTRY APPLICATIONS, BY REGION, 2020–2027 (USD BILLION) 109
7.5.3 OTHER X-RAY APPLICATIONS 109
TABLE 60 DIAGNOSTIC IMAGING SERVICES MARKET FOR OTHER X-RAY APPLICATIONS, BY REGION, 2020–2027 (USD BILLION) 109
7.6 NUCLEAR IMAGING SERVICES 110
TABLE 61 DIAGNOSTIC IMAGING SERVICES MARKET FOR NUCLEAR IMAGING, BY APPLICATIONS, 2020–2027 (USD BILLION) 110
7.6.1 NEUROLOGY 110
7.6.1.1 PET system to provide structural and functional information on brain functions 110
TABLE 62 NUCLEAR IMAGING SERVICES MARKET FOR NEUROLOGY APPLICATIONS, BY REGION, 2020–2027 (USD BILLION) 111
7.6.2 ONCOLOGY 111
7.6.2.1 Nuclear imaging systems distinguish benign and malignant tumors 111
TABLE 63 NUCLEAR IMAGING SERVICES MARKET FOR ONCOLOGY APPLICATIONS, BY REGION, 2020–2027 (USD BILLION) 111
7.6.3 CARDIOVASCULAR 112
7.6.3.1 High prevalence of CVD to drive market 112
TABLE 64 NUCLEAR IMAGING SERVICES MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2020–2027 (USD BILLION) 112
7.6.4 OTHER NUCLEAR IMAGING APPLICATIONS 113
TABLE 65 NUCLEAR IMAGING SERVICES MARKET FOR OTHER NUCLEAR IMAGING APPLICATIONS, BY REGION, 2020–2027 (USD BILLION) 113
7.7 MAMMOGRAPHY 113
7.7.1 RISING CASES OF BREAST CANCER WORLDWIDE TO DRIVE MARKET 113
TABLE 66 DIAGNOSTIC IMAGING SERVICES FOR MAMMOGRAPHY APPLICATIONS, BY REGION, 2020–2027 (USD BILLION) 114
8 DIAGNOSTIC IMAGING SERVICES MARKET, BY TECHNOLOGY 115
8.1 INTRODUCTION 116
TABLE 67 DIAGNOSTIC IMAGING SERVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD BILLION) 116
8.2 2D IMAGING TECHNOLOGY 116
8.2.1 WIDE USAGE OF 2D IMAGING TECHNOLOGY ACROSS HEALTHCARE FACILITIES TO SUPPORT MARKET GROWTH 116
TABLE 68 DIAGNOSTIC IMAGING SERVICES MARKET FOR 2D IMAGING TECHNOLOGY, BY REGION, 2020–2027 (USD BILLION) 117
8.3 3D/4D IMAGING TECHNOLOGY 117
8.3.1 INCREASING NUMBER OF COMPANIES DEVELOPING 3D IMAGING EQUIPMENT TO DRIVE MARKET 117
TABLE 69 DIAGNOSTIC IMAGING SERVICES MARKET FOR 3D/4D IMAGING TECHNOLOGY, BY REGION, 2020–2027 (USD BILLION) 118
9 DIAGNOSTIC IMAGING SERVICES MARKET, BY END USER 119
9.1 INTRODUCTION 120
TABLE 70 DIAGNOSTIC IMAGING SERVICES MARKET, BY END USER, 2020–2027 (USD BILLION) 120
9.2 HOSPITALS 120
9.2.1 RISING NUMBER OF DIAGNOSTIC IMAGING PROCEDURES PERFORMED IN HOSPITALS TO DRIVE MARKET 120
TABLE 71 DIAGNOSTIC IMAGING SERVICES MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD BILLION) 121
9.3 DIAGNOSTIC IMAGING CENTERS 121
9.3.1 GROWING ESTABLISHMENT OF PRIVATE IMAGING CENTERS TO DRIVE MARKET 121
TABLE 72 DIAGNOSTIC IMAGING SERVICES MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2020–2027 (USD BILLION) 122
9.4 AMBULATORY CARE CENTERS 122
9.4.1 GROWING NUMBER OF ACCS TO SUPPORT MARKET GROWTH 122
TABLE 73 DIAGNOSTIC IMAGING SERVICES MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2020–2027 (USD BILLION) 123
9.5 RESEARCH & ACADEMIA 123
9.5.1 INCREASING RESEARCH ACTIVITIES IN CLINICAL APPLICATIONS TO SUPPORT MARKET GROWTH 123
TABLE 74 DIAGNOSTIC IMAGING SERVICES MARKET FOR RESEARCH & ACADEMIA, BY REGION, 2020–2027 (USD BILLION) 124
10 DIAGNOSTIC IMAGING SERVICES MARKET, BY REGION 125
10.1 INTRODUCTION 126
TABLE 75 DIAGNOSTIC IMAGING SERVICES MARKET, BY REGION, 2020–2027 (USD BILLION) 126
10.2 NORTH AMERICA 126
FIGURE 27 NORTH AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET SNAPSHOT 127
TABLE 76 NORTH AMERICA: DIAGNOSTIC IMAGING MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 127
TABLE 77 NORTH AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION) 128
TABLE 78 NORTH AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET, BY END USER, 2020–2027 (USD BILLION) 128
TABLE 79 NORTH AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR X-RAY APPLICATIONS, 2020–2027 (USD BILLION) 128
TABLE 80 NORTH AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR MAGNETIC RESONANCE IMAGING (MRI) APPLICATIONS, 2020–2027 (USD BILLION) 129
TABLE 81 NORTH AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR COMPUTED TOMOGRAPHY (CT) APPLICATIONS, 2020–2027 (USD BILLION) 129
TABLE 82 NORTH AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR ULTRASOUND APPLICATIONS, 2020–2027 (USD BILLION) 130
TABLE 83 NORTH AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR NUCLEAR IMAGING APPLICATIONS, 2020–2027 (USD BILLION) 130
TABLE 84 NORTH AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET, BY END USER, 2020–2027 (USD BILLION) 131
10.2.1 US 131
10.2.1.1 Increasing volume of diagnostic imaging procedures to drive market 131
TABLE 85 US: KEY GROWTH MACROINDICATORS 132
TABLE 86 US: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION) 132
10.2.2 CANADA 133
10.2.2.1 Rising collaborations and investments by diagnostic imaging companies to support market growth 133
TABLE 87 CANADA: MAJOR INDICATORS OF MARKET GROWTH 133
TABLE 88 CANADA: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION) 134
10.3 EUROPE 135
FIGURE 28 EUROPE: CANCER PREVALENCE, BY COUNTRY, 2012–2030 135
TABLE 89 EUROPE: DIAGNOSTIC IMAGING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 136
TABLE 90 EUROPE: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION) 136
TABLE 91 EUROPE: DIAGNOSTIC IMAGING SERVICES MARKET FOR X-RAY APPLICATIONS, 2020–2027 (USD BILLION) 137
TABLE 92 EUROPE: DIAGNOSTIC IMAGING SERVICES MARKET FOR MAGNETIC RESONANCE IMAGING (MRI) APPLICATIONS, 2020–2027 (USD BILLION) 137
TABLE 93 EUROPE: DIAGNOSTIC IMAGING SERVICES MARKET FOR COMPUTED TOMOGRAPHY (CT) APPLICATIONS, 2020–2027 (USD BILLION) 137
TABLE 94 EUROPE: DIAGNOSTIC IMAGING SERVICES MARKET FOR ULTRASOUND APPLICATIONS, 2020–2027 (USD BILLION) 138
TABLE 95 EUROPE: DIAGNOSTIC IMAGING SERVICES MARKET FOR NUCLEAR IMAGING APPLICATIONS, 2020–2027 (USD BILLION) 138
TABLE 96 EUROPE: DIAGNOSTIC IMAGING SERVICES MARKET, BY END USER, 2020–2027 (USD BILLION) 139
10.3.1 GERMANY 139
10.3.1.1 Rising volume of imaging procedures to drive market 139
TABLE 97 GERMANY: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION) 140
10.3.2 UK 140
10.3.2.1 Government initiatives to promote diagnostic imaging services to drive market 140
TABLE 98 UK: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION) 141
10.3.3 FRANCE 141
10.3.3.1 High incidence of Alzheimer's and other neurological conditions to drive demand for MRI scans 141
TABLE 99 FRANCE: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION) 142
10.3.4 ITALY 142
10.3.4.1 Rising senior population coupled with an established healthcare system to support market growth 142
TABLE 100 ITALY: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION) 143
10.3.5 SPAIN 143
10.3.5.1 Rising expansion of diagnostic imaging service providers to drive market demand 143
TABLE 101 SPAIN: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION) 144
10.3.6 REST OF EUROPE (ROE) 144
TABLE 102 REST OF EUROPE: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION) 145
10.4 ASIA PACIFIC 146
FIGURE 29 ASIA PACIFIC: CANCER PREVALENCE, 2012–2030 146
FIGURE 30 ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET SNAPSHOT 147
TABLE 103 ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 148
TABLE 104 ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION) 148
TABLE 105 ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET FOR X-RAY APPLICATIONS, 2020–2027 (USD BILLION) 149
TABLE 106 ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET FOR MAGNETIC RESONANCE IMAGING (MRI) APPLICATIONS, 2020–2027 (USD BILLION) 149
TABLE 107 ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET FOR COMPUTED TOMOGRAPHY (CT) APPLICATIONS, 2020–2027 (USD BILLION) 149
TABLE 108 ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET FOR ULTRASOUND APPLICATIONS, 2020–2027 (USD BILLION) 150
TABLE 109 ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET FOR NUCLEAR IMAGING APPLICATIONS, 2020–2027 (USD BILLION) 150
TABLE 110 ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET, BY END USER, 2020–2027 (USD BILLION) 151
10.4.1 CHINA 151
10.4.1.1 Expansion of diagnostic imaging facilities to support market growth 151
TABLE 111 CHINA: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION) 152
10.4.2 JAPAN 152
10.4.2.1 Rapid adoption of advanced technologies and rising investments in diagnostic imaging procedures to support market growth 152
TABLE 112 JAPAN: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION) 153
10.4.3 INDIA 153
10.4.3.1 Rising number of imaging centers and growing target patient pool to support market growth 153
TABLE 113 INDIA: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION) 154
10.4.4 SOUTH KOREA 154
10.4.4.1 Rising focus on integration of AI in diagnostic imaging to support market growth 154
TABLE 114 SOUTH KOREA: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION) 155
10.4.5 AUSTRALIA 155
10.4.5.1 Government funding to increase accessibility of diagnostic imaging services to drive market 155
TABLE 115 AUSTRALIA: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION) 156
10.4.6 REST OF ASIA PACIFIC (ROAPAC) 156
TABLE 116 REST OF ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION) 157
10.5 LATIN AMERICA 157
10.5.1 RISING GERIATRIC POPULATION AND INCREASING DISEASE INCIDENCE TO SUPPORT MARKET GROWTH 157
TABLE 117 LATIN AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION) 158
TABLE 118 LATIN AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR X-RAY IMAGING APPLICATIONS, 2020–2027 (USD BILLION) 158
TABLE 119 LATIN AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR MAGNETIC RESONANCE IMAGING (MRI) APPLICATIONS, 2020–2027 (USD BILLION) 159
TABLE 120 LATIN AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR COMPUTED TOMOGRAPHY (CT) APPLICATIONS, 2020–2027 (USD BILLION) 159
TABLE 121 LATIN AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR ULTRASOUND APPLICATIONS, 2020–2027 (USD BILLION) 160
TABLE 122 LATIN AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR NUCLEAR IMAGING APPLICATIONS, 2020–2027 (USD BILLION) 160
TABLE 123 LATIN AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET, BY END USER, 2020–2027 (USD BILLION) 161
10.6 MIDDLE EAST & AFRICA 161
10.6.1 IMPROVEMENTS IN HEALTHCARE SYSTEMS TO SUPPORT MARKET UPTAKE OF DIAGNOSTIC IMAGING SYSTEMS 161
TABLE 124 MIDDLE EAST & AFRICA: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION) 162
TABLE 125 MIDDLE EAST & AFRICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR X-RAY IMAGING APPLICATIONS, 2020–2027 (USD BILLION) 162
TABLE 126 MIDDLE EAST & AFRICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR MAGNETIC RESONANCE IMAGING (MRI) APPLICATIONS, 2020–2027 (USD BILLION) 163
TABLE 127 MIDDLE EAST & AFRICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR COMPUTED TOMOGRAPHY (CT) APPLICATIONS, 2020–2027 (USD BILLION) 163
TABLE 128 MIDDLE EAST & AFRICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR ULTRASOUND APPLICATIONS, 2020–2027 (USD BILLION) 164
TABLE 129 MIDDLE EAST & AFRICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR NUCLEAR IMAGING APPLICATIONS, 2020–2027 (USD BILLION) 164
TABLE 130 MIDDLE EAST & AFRICA: DIAGNOSTIC IMAGING SERVICES MARKET, BY END USER, 2020–2027 (USD BILLION) 165
11 COMPETITIVE LANDSCAPE 166
11.1 OVERVIEW 166
11.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN 166
FIGURE 31 OVERVIEW OF STRATEGIES ADOPTED BY COMPANIES 167
11.3 REVENUE ANALYSIS 168
FIGURE 32 REVENUE SHARE ANALYSIS OF TOP FIVE PLAYERS (2018−2021) 168
11.4 DIAGNOSTIC IMAGING SERVICES MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 168
FIGURE 33 MARKET SHARE ANALYSIS, 2021 169
TABLE 131 DIAGNOSTIC IMAGING SERVICES MARKET: DEGREE OF COMPETITION 169
11.5 COMPANY EVALUATION QUADRANT FOR MAJOR PLAYERS (AS OF 2021) 170
11.5.1 STARS 170
11.5.2 EMERGING LEADERS 171
11.5.3 PERVASIVE PLAYERS 171
11.5.4 PARTICIPANTS 171
FIGURE 34 DIAGNOSTIC IMAGING SERVICES MARKET: COMPANY EVALUATION QUADRANT (2021) 172
11.6 COMPANY EVALUATION QUADRANT (SMES/START-UPS) 173
11.6.1 PROGRESSIVE COMPANIES 173
11.6.2 RESPONSIVE COMPANIES 173
11.6.3 DYNAMIC COMPANIES 173
11.6.4 STARTING BLOCKS 173
FIGURE 35 DIAGNOSTIC IMAGING SERVICES MARKET: COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS) 174
11.7 COMPETITIVE BENCHMARKING 175
TABLE 132 OVERALL FOOTPRINT ANALYSIS 175
TABLE 133 MODALITY FOOTPRINT ANALYSIS 176
TABLE 134 REGIONAL FOOTPRINT ANALYSIS 177
11.8 COMPETITIVE SCENARIO (2019–2022) 178
11.8.1 DEALS 178
11.8.2 OTHER DEVELOPMENTS 179
12 COMPANY PROFILES 180
(Business Overview, Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1 RADNET, INC. 180
TABLE 135 RADNET, INC: BUSINESS OVERVIEW 180
FIGURE 36 RADNET, INC: COMPANY SNAPSHOT (2021) 181
TABLE 136 RADNET, INC: SERVICE OFFERINGS 181
12.2 SONIC HEALTHCARE 184
TABLE 137 SONIC HEALTHCARE: BUSINESS OVERVIEW 184
FIGURE 37 SONIC HEALTHCARE: COMPANY SNAPSHOT (2021) 185
TABLE 138 SONIC HEALTHCARE: SERVICE OFFERINGS 185
12.3 AKUMIN INC. 188
TABLE 139 AKUMIN INC. BUSINESS OVERVIEW 188
FIGURE 38 AKUMIN INC: COMPANY SNAPSHOT (2021) 189
TABLE 140 AKUMIN INC: SERVICE OFFERINGS 189
12.4 HEALIUS LIMITED 191
TABLE 141 HEALIUS LIMITED: BUSINESS OVERVIEW 191
FIGURE 39 HEALIUS LIMITED: COMPANY SNAPSHOT (2021) 191
TABLE 142 HEALIUS LIMITED: SERVICE OFFERINGS 192
12.5 DIGNITY HEALTH 193
TABLE 143 DIGNITY HEALTH: BUSINESS OVERVIEW 193
FIGURE 40 DIGNITY HEALTH: COMPANY SNAPSHOT (2021) 193
TABLE 144 DIGNITY HEALTHCARE: SERVICE OFFERINGS 194
12.6 NOVANT HEALTH 195
TABLE 145 NOVANT HEALTH: BUSINESS OVERVIEW 195
FIGURE 41 NOVANT HEALTH: COMPANY SNAPSHOT (2021) 195
TABLE 146 NOVANT HEALTH: SERVICE OFFERINGS 196
12.7 ALLIANCE MEDICAL 197
TABLE 147 ALLIANCE MEDICAL: BUSINESS OVERVIEW 197
TABLE 148 ALLIANCE MEDICAL: SERVICE OFFERINGS 197
12.8 INHEALTH GROUP 199
TABLE 149 INHEALTH GROUP: BUSINESS OVERVIEW 199
TABLE 150 INHEALTH GROUP: SERVICE OFFERINGS 199
12.9 APEX RADIOLOGY 201
TABLE 151 APEX RADIOLOGY: BUSINESS OVERVIEW 201
TABLE 152 APEX RADIOLOGY: SERVICE OFFERINGS 201
12.10 CONCORD MEDICAL SERVICES HOLDINGS LIMITED 202
TABLE 153 CONCORD MEDICAL SERVICES HOLDINGS LIMITED: BUSINESS OVERVIEW 202
FIGURE 42 CONCORD MEDICAL SERVICES HOLDINGS LIMITED:
COMPANY SNAPSHOT (2021) 203
TABLE 154 CONCORD MEDICAL SERVICES HOLDINGS LIMITED: SERVICE OFFERINGS 203
12.11 RAYUS RADIOLOGY (CENTER FOR DIAGNOSTIC IMAGING, INC.) 204
TABLE 155 RAYUS RADIOLOGY: BUSINESS OVERVIEW 204
TABLE 156 RAYUS RADIOLOGY: SERVICE OFFERINGS 204
12.12 UNILABS 206
TABLE 157 UNILABS: BUSINESS OVERVIEW 206
TABLE 158 UNILABS: SERVICE OFFERINGS 206
12.13 AFFIDEA 208
TABLE 159 AFFIDEA: BUSINESS OVERVIEW 208
TABLE 160 AFFIDEA: SERVICE OFFERINGS 208
12.14 I-MED RADIOLOGY NETWORK 210
TABLE 161 I-MED RADIOLOGY NETWORK: BUSINESS OVERVIEW 210
TABLE 162 I-MED RADIOLOGY NETWORK: SERVICE OFFERINGS 210
12.15 CAPITOL IMAGING SERVICES 212
TABLE 163 CAPITOL IMAGING SERVICES: BUSINESS OVERVIEW 212
TABLE 164 CAPITOL IMAGING SERVICES: SERVICE OFFERINGS 212
12.16 SIMONMED 213
TABLE 165 SIMONMED: BUSINESS OVERVIEW 213
TABLE 166 SIMONMED: SERVICE OFFERINGS 213
12.17 CANADA DIAGNOSTIC CENTRES (CDC) 214
TABLE 167 CANADA DIAGNOSTIC CENTRES: BUSINESS OVERVIEW 214
TABLE 168 CANADA DIAGNOSTIC CENTRES: SERVICE OFFERINGS 214
12.18 SHIELDS HEALTH CARE GROUP 216
TABLE 169 SHIELDS HEALTH CARE GROUP: BUSINESS OVERVIEW 216
TABLE 170 SHIELDS HEALTH CARE GROUP: SERVICE OFFERINGS 216
12.19 ENVISION RADIOLOGY 217
TABLE 171 ENVISION RADIOLOGY: BUSINESS OVERVIEW 217
TABLE 172 ENVISION RADIOLOGY: SERVICE OFFERINGS 217
12.20 PROGRESSIVE RADIOLOGY 218
TABLE 173 PROGRESSIVE RADIOLOGY: BUSINESS OVERVIEW 218
TABLE 174 PROGRESSIVE RADIOLOGY: SERVICE OFFERINGS 218
 
12.21 OTHER PLAYERS 219
12.21.1 QSCAN SERVICES PTY LTD 219
12.21.2 PRP DIAGNOSTIC IMAGING 220
12.21.3 INOVA 220
12.21.4 ATLANTIC MEDICAL IMAGING 221
12.21.5 ADVANCED DIAGNOSTICS HEALTHCARE SYSTEM, INC. 221
*Details on Business Overview, Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 222
13.1 DISCUSSION GUIDE 222
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 227
13.3 CUSTOMIZATION OPTIONS 229
13.4 RELATED REPORTS 230
13.5 AUTHOR DETAILS 231